Cargando…
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
PARPi, in combination with ionizing radiation, has demonstrated the ability to enhance cellular radiosensitivity in different tumors. The rationale is that the exposure to radiation leads to both physical and biochemical damage to DNA, prompting cells to initiate three primary mechanisms for DNA rep...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455664/ https://www.ncbi.nlm.nih.gov/pubmed/37629155 http://dx.doi.org/10.3390/ijms241612978 |